Post Test and Evaluation

Please note that to receive credit you must achieve a score of at least 70%.
Credit will be uploaded to CPE Monitor within 4 weeks of successful completion of the activity.

Post-Activity Test
1.The therapeutic target of epoprostenal is within the: (Required.)
2.Treprostinil is available in all of the following formulations except: (Required.)
3.The use of nitrates is contraindicated in patients receiving a phosphodiesterase type 5 (PDE-5) inhibitor. (Required.)
4.Pulmonary arterial hypertension is defined as having a mean pulmonary arterial pressure (mPAP) of: (Required.)
5.Current PAH therapy targets all of the following pathways except: (Required.)
Privacy & Cookie Notice